Bayer increases Roundup litigation provisions by $1.37 billion

German pharmaceutical company Bayer BAYN said on Thursday it had set aside an additional 1.2 billion euros ($1.37 billion) in provisions to address ongoing Roundup litigation in the United States.

($1 = 0.8759 euros)